Milbar Recalls B Prox 10 Anti-blemish Wash Due to Microbial Contamination
Milbar Laboratories is recalling 3,477 bottles of B Prox 10 Anti-blemish Wash due to microbial contamination. Consumers should stop using the product and return it to the point of purchase.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text identifies the agency classification as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe), as the agency's own classification mandates a minimum score of 4.
Plain-English summary
Milbar Laboratories, Inc. is voluntarily recalling 3,477 plastic bottles of B Prox 10 Anti-blemish Wash (Benzoyl peroxide 10%), 200 mL bottles. The product was manufactured by Dermatologic Cosmetic Laboratories in East Haven, CT, and distributed within the United States and Puerto Rico.
The recall was initiated due to microbial contamination of the non-sterile product. The affected lots are # ET507-0 (Expiration 5/27/2019) and # GU894-8 (Expiration 7/20/2010).
Consumers who have purchased this product should stop using it immediately and return it to the point of purchase for a refund. The FDA classifies this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- B Prox 10 Anti-blemish Wash, (Benzoyl peroxide 10%), 200 mL bottles, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA
- Manufacturer
- Milbar Laboratories, Inc.
- Category
- Drug — Dermatologic
- Hazard
- Affected units
- 3,477
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: # ET507-0
- Exp. 5/27/2019
- GU894-8
- Exp. 7/20/2010
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 4 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Milbar Laboratories, Inc.
See all →- ModerateMilbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Willa Pore Perfector Pads Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL SA Scalp Therapy Shampoo Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Malin + Goetz Salicylic Gel Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL Alpha Beta Gel Toner Due to GMP Deviations
FDA (Drugs) · 2020-11-25
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateMilbar Recalls DCL B Prox10 Anti-Blemish Wash Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- ModerateMilbar Recalls MD Complete Breakout Treatment Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL Clear Skin Anti-Blemish Hydrator Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- SevereProactiv Emergency Blemish Relief recalled for benzene contamination
FDA (Drugs) · 2025-04-16
- ModerateMilbar Recalls Willa Pore Perfector Pads Due to GMP Deviations
FDA (Drugs) · 2020-11-25